KUALITAS HIDUP PADA PASIEN KANKER ANOGENITAL YANG DI NILAI DENGAN INDEKS EUROPEAN QUALITY OF LIFE 5 DIMENSION 5 LEVEL (EQ-5D 5L) DI RSUD PROF. DR. MARGONO SOEKARDJO PURWOKERTO

SULASTRI, . (2015) KUALITAS HIDUP PADA PASIEN KANKER ANOGENITAL YANG DI NILAI DENGAN INDEKS EUROPEAN QUALITY OF LIFE 5 DIMENSION 5 LEVEL (EQ-5D 5L) DI RSUD PROF. DR. MARGONO SOEKARDJO PURWOKERTO. Bachelor thesis, UNIVERSITAS MUHAMMADIYAH PURWOKERTO.

Preview	Text Sulastri Cover.pdf Download (868kB) | Preview
Preview	Text Sulastri BAB I.pdf Download (607kB) | Preview
Preview	Text Sulastri BAB II.pdf Download (736kB) | Preview
	Text Sulastri BAB III.pdf Restricted to Repository staff only Download (716kB)
	Text Sulastri BAB IV.pdf Restricted to Repository staff only Download (708kB)
	Text Sulastri BAB V.pdf Restricted to Repository staff only Download (598kB)
Preview	Text Sulastri Daftar Pustaka.pdf Download (1MB) | Preview
	Text Sulastri Lampiran.pdf Restricted to Repository staff only Download (1MB)

Abstract

Measuring quality of life of Anogenital cancer patients, it was necessary to consider the effect of cancer treatment and see the effectifness of patients therapy. The aimed of study to describe the quality of life in patients with anogenital cancers who undergoing a single treatment or in combination, and determine is there any difference in the quality of life based recevaid treatment of anogenital cancer in RSUD Prof. Dr. Margono Soekardjo Purwokerto using questionnaire European Quality of Life-5 Dimensions (EQ-5D) 5L. This study is descriptive analytic using cross sectional approach, sampling were done by total sampling of anogenital cancer patients in RSUD Prof. Dr. Margono Soekardjo Purwokerto from 2010 until 2015, and the EQ-5D 5L questionnaire conducted by Home visit. There is 17 anogenital cancers patients with the most of treatment type is chemotherapy-operation (35,29%), the average age of respondents are 48,2 years. Overall anogenital cancer and its treatment negative result on the quality of life of patients. Most effected result the quality of life anogenital cancer patients is pain / discomfort (52,94%), followed by the dimension of daily activities (47,05%), the dimension anxiety/depression, the dimensions mobility (41,17%), and self-care dimension (17,64%). The average value of EQ-VAS anogenital cancer patients are 69,48 (SD=25,43). Quality of life anogenital cancer patients in RSUD Prof. Dr. Margono Soekardjo Purwokerto showed significant difference in patients receiving chemoradiation and surgery treatment, compared with other types of treatment.

Actions (login required)

View Item